title: Topical anti-inflammatory effects of isorhamnetin glycosides isolated from Opuntia ficus-indica.
abstract: Opuntia ficus-indica (OFI) has been widely used in Mexico as a food and for the treatment of different health disorders such as inflammation and skin aging. Its biological properties have been attributed to different phytochemicals such as the isorhamnetin glycosides which are the most abundant flavonoids. Moreover, these compounds are considered a chemotaxonomic characteristic of OFI species. The aim of this study was to evaluate the effect of OFI extract and its isorhamnetin glycosides on different inflammatory markers in vitro and in vivo. OFI extract was obtained by alkaline hydrolysis of OFI cladodes powder and pure compounds were obtained by preparative chromatography. Nitric oxide (NO), cyclooxygenase-2 (COX-2), tumor necrosis factor- (TNF-) α, and interleukin- (IL-) 6 production were measured. NO production was tested in lipopolysaccharide-stimulated RAW 264.7 cells while in vivo studies were carried on croton oil-induced ear edema model. OFI extract and diglycoside isorhamnetin-glucosyl-rhamnoside (IGR) at 125 ng/mL suppressed the NO production in vitro (73.5 ± 4.8% and 68.7 ± 5.0%, resp.) without affecting cell viability. Likewise, IGR inhibited the ear edema (77.4 ± 5.7%) equating the indomethacin effects (69.5 ± 5.3%). Both IGR and OFI extract significantly inhibited the COX-2, TNF-α, and IL-6 production. IGR seems to be a suitable natural compound for development of new anti-inflammatory ingredient.
authors.affiliation: Centro de Biotecnología-FEMSA, Tecnológico de Monterrey, Avenida Eugenio Garza Sada 2501 Sur, 64849 Monterrey, NL, Mexico.
authors.forename: Marilena
authors.initials: M
authors.lastname: Antunes-Ricardo
authors.affiliation: Centro de Biotecnología-FEMSA, Tecnológico de Monterrey, Avenida Eugenio Garza Sada 2501 Sur, 64849 Monterrey, NL, Mexico.
authors.forename: Janet A
authors.initials: JA
authors.lastname: Gutiérrez-Uribe
authors.affiliation: Centro de Biotecnología-FEMSA, Tecnológico de Monterrey, Avenida Eugenio Garza Sada 2501 Sur, 64849 Monterrey, NL, Mexico.
authors.forename: Carlos
authors.initials: C
authors.lastname: Martínez-Vitela
authors.affiliation: Centro de Biotecnología-FEMSA, Tecnológico de Monterrey, Avenida Eugenio Garza Sada 2501 Sur, 64849 Monterrey, NL, Mexico.
authors.forename: Sergio O
authors.initials: SO
authors.lastname: Serna-Saldívar
mesh_terms: D000818:Animals; D000893:Anti-Inflammatory Agents / Q000008:administration & dosage / Q000737:chemistry; D016207:Cytokines / Q000276:immunology; D004305:Dose-Response Relationship, Drug; D006027:Glycosides / Q000008:administration & dosage* / Q000737:chemistry; D008297:Male; D029747:Opuntia / Q000737:chemistry*; D010032:Otitis Externa / Q000188:drug therapy* / Q000276:immunology*; D010936:Plant Extracts / Q000008:administration & dosage* / Q000737:chemistry; D011794:Quercetin / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000737:chemistry; D051381:Rats; D017208:Rats, Wistar; D016896:Treatment Outcome
chemical_list: D000893:Anti-Inflammatory Agents; D016207:Cytokines; D006027:Glycosides; D010936:Plant Extracts; C047368:3-methylquercetin; D011794:Quercetin
references.citation: J Pharm Sci. 1999 Oct;88(10):955-8
references.pmid: 10514338
references.citation: Eur J Pharmacol. 2003 Feb 7;461(1):53-61
references.pmid: 12568916
references.citation: Biochem Pharmacol. 2003 Apr 1;65(7):1199-206
references.pmid: 12663055
references.citation: Int J Immunopharmacol. 1992 Aug;14(6):1045-50
references.pmid: 1428359
references.citation: Pharmacol Res. 2003 Dec;48(6):601-6
references.pmid: 14527825
references.citation: Bioorg Med Chem. 2005 Apr 1;13(7):2381-8
references.pmid: 15755640
references.citation: J Invest Dermatol. 2006 Dec;126(12):2565-75
references.pmid: 17108903
references.citation: J Pharm Pharmacol. 2007 May;59(5):703-9
references.pmid: 17524236
references.citation: Mediators Inflamm. 2007;2007:45673
references.pmid: 18274639
references.citation: J Invest Dermatol. 2008 Nov;128(11):2606-14
references.pmid: 18463678
references.citation: J Biol Chem. 2008 Sep 19;283(38):26161-8
references.pmid: 18606807
references.citation: J Ethnopharmacol. 2008 Sep 2;119(1):172-8
references.pmid: 18638535
references.citation: J Ethnopharmacol. 2009 Jan 21;121(2):333-7
references.pmid: 19041703
references.citation: Int Immunopharmacol. 2009 Mar;9(3):268-76
references.pmid: 19111632
references.citation: Chem Pharm Bull (Tokyo). 2009 Mar;57(3):280-2
references.pmid: 19252320
references.citation: J Ethnopharmacol. 2009 Jul 15;124(2):228-32
references.pmid: 19397977
references.citation: J Ethnopharmacol. 2009 May 4;123(1):149-54
references.pmid: 19429354
references.citation: J Ethnopharmacol. 2009 Sep 7;125(2):286-90
references.pmid: 19577625
references.citation: J Agric Food Chem. 2009 Nov 11;57(21):10323-30
references.pmid: 19831414
references.citation: J Ethnopharmacol. 2010 Feb 17;127(3):589-95
references.pmid: 20034551
references.citation: Phytother Res. 2010 Jul;24(7):1071-7
references.pmid: 20041431
references.citation: J Ethnopharmacol. 2010 Mar 2;128(1):123-30
references.pmid: 20051261
references.citation: Inflamm Res. 2010 Sep;59(9):711-21
references.pmid: 20221843
references.citation: Free Radic Biol Med. 2010 Dec 1;49(11):1603-16
references.pmid: 20840865
references.citation: Pain. 2010 Dec;151(3):843-52
references.pmid: 20934254
references.citation: J Invest Dermatol. 2011 Mar;131(3):677-87
references.pmid: 21085185
references.citation: Cytokine Growth Factor Rev. 2011 Apr;22(2):83-9
references.pmid: 21377916
references.citation: Molecules. 2011 Apr 18;16(4):3338-44
references.pmid: 21512441
references.citation: J Agric Food Chem. 2011 Jul 13;59(13):7054-61
references.pmid: 21598948
references.citation: J Med Food. 2012 Mar;15(3):278-87
references.pmid: 22082098
references.citation: Arch Pharm Res. 2011 Dec;34(12):2101-7
references.pmid: 22210036
references.citation: Eur J Pharm Sci. 2012 Dec 18;47(5):857-64
references.pmid: 22609526
references.citation: Evid Based Complement Alternat Med. 2012;2012:142087
references.pmid: 22899950
references.citation: J Cell Biochem. 2013 Feb;114(2):336-45
references.pmid: 22930571
references.citation: BMC Complement Altern Med. 2012 Oct 03;12:171
references.pmid: 23031211
references.citation: Carbohydr Res. 2012 Dec 15;364:49-53
references.pmid: 23174526
references.citation: J Ethnopharmacol. 2013 Jun 21;148(1):271-6
references.pmid: 23612420
references.citation: J Ethnopharmacol. 2013 Jul 30;148(3):901-8
references.pmid: 23743057
references.citation: Inflammopharmacology. 2014 Apr;22(2):115-26
references.pmid: 23990384
references.citation: Biomol Ther (Seoul). 2012 Nov;20(6):532-7
references.pmid: 24009846
references.citation: Arch Pharm Res. 2014 Jul;37(7):845-51
references.pmid: 24014305
references.citation: Arch Pharm Res. 2014;37(9):1159-68
references.pmid: 24446110
references.citation: Semin Immunol. 2014 Feb;26(1):54-74
references.pmid: 24552665
references.citation: Phytother Res. 2014 Sep;28(9):1359-66
references.pmid: 24610745
references.citation: Molecules. 2014 Jul 15;19(7):10261-78
references.pmid: 25029073
references.citation: Inflammation. 2015 Apr;38(2):858-70
references.pmid: 25139581
references.citation: Biochim Biophys Acta. 2014 Dec;1840(12):3311-9
references.pmid: 25152356
references.citation: Cytokine Growth Factor Rev. 2014 Aug;25(4):453-72
references.pmid: 25169849
references.citation: Plant Foods Hum Nutr. 2014 Dec;69(4):331-6
references.pmid: 25186940
references.citation: Biomed Res Int. 2014;2014:327452
references.pmid: 25197638
references.citation: Eur J Pharmacol. 2014 Dec 5;744:147-56
references.pmid: 25446915
references.citation: Food Res Int. 2014 Oct;64:864-872
references.pmid: 30011726
references.citation: Inflamm Res. 1995 Sep;44(9):372-5
references.pmid: 8846194
references.citation: Front Biosci. 1997 Jan 01;2:d12-26
references.pmid: 9159205